16-55823658-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001025195.2(CES1):​c.431G>A​(p.Gly144Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.01 in 151,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).

Frequency

Genomes: 𝑓 0.010 ( 0 hom., cov: 39)
Exomes 𝑓: 0.012 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CES1
NM_001025195.2 missense

Scores

3
5
10

Clinical Significance

drug response reviewed by expert panel P:1B:1O:2

Conservation

PhyloP100: 0.892

Publications

140 publications found
Variant links:
Genes affected
CES1 (HGNC:1863): (carboxylesterase 1) This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This enzyme is the major liver enzyme and functions in liver drug clearance. Mutations of this gene cause carboxylesterase 1 deficiency. Three transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03447321).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CES1NM_001025195.2 linkc.431G>A p.Gly144Glu missense_variant Exon 4 of 14 ENST00000360526.8 NP_001020366.1 P23141-2
CES1NM_001025194.2 linkc.428G>A p.Gly143Glu missense_variant Exon 4 of 14 NP_001020365.1 P23141-1
CES1NM_001266.5 linkc.428G>A p.Gly143Glu missense_variant Exon 4 of 14 NP_001257.4 P23141-3
CES1XM_005255774.3 linkc.431G>A p.Gly144Glu missense_variant Exon 4 of 14 XP_005255831.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CES1ENST00000360526.8 linkc.431G>A p.Gly144Glu missense_variant Exon 4 of 14 1 NM_001025195.2 ENSP00000353720.4 P23141-2

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1519
AN:
151544
Hom.:
0
Cov.:
39
show subpopulations
Gnomad AFR
AF:
0.00237
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0106
Gnomad ASJ
AF:
0.0235
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00685
Gnomad FIN
AF:
0.0108
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0148
Gnomad OTH
AF:
0.0101
GnomAD2 exomes
AF:
0.0109
AC:
2725
AN:
249588
AF XY:
0.0112
show subpopulations
Gnomad AFR exome
AF:
0.00179
Gnomad AMR exome
AF:
0.00693
Gnomad ASJ exome
AF:
0.0260
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0114
Gnomad NFE exome
AF:
0.0148
Gnomad OTH exome
AF:
0.0158
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0119
AC:
17324
AN:
1450200
Hom.:
0
Cov.:
35
AF XY:
0.0120
AC XY:
8645
AN XY:
721462
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00248
AC:
83
AN:
33448
American (AMR)
AF:
0.00749
AC:
334
AN:
44588
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
663
AN:
25818
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.00658
AC:
566
AN:
86044
European-Finnish (FIN)
AF:
0.0127
AC:
674
AN:
52988
Middle Eastern (MID)
AF:
0.0110
AC:
63
AN:
5732
European-Non Finnish (NFE)
AF:
0.0129
AC:
14171
AN:
1101962
Other (OTH)
AF:
0.0128
AC:
768
AN:
59922
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.266
Heterozygous variant carriers
0
1816
3632
5448
7264
9080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
508
1016
1524
2032
2540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0100
AC:
1519
AN:
151662
Hom.:
0
Cov.:
39
AF XY:
0.00930
AC XY:
690
AN XY:
74154
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00236
AC:
98
AN:
41518
American (AMR)
AF:
0.0106
AC:
161
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.0235
AC:
81
AN:
3440
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00686
AC:
33
AN:
4814
European-Finnish (FIN)
AF:
0.0108
AC:
114
AN:
10566
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0148
AC:
1002
AN:
67602
Other (OTH)
AF:
0.0100
AC:
21
AN:
2098
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.293
Heterozygous variant carriers
0
104
208
313
417
521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0134
Hom.:
0
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00942
AC:
81
ExAC
AF:
0.0144
AC:
1747

ClinVar

Significance: drug response
Submissions summary: Pathogenic:1Benign:1Other:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Pathogenic:1Benign:1
May 15, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CES1: PM1, PS4:Moderate, PP4, PS3:Supporting -

clopidogrel response - Efficacy Other:1
Mar 24, 2021
PharmGKB
Significance:drug response
Review Status:reviewed by expert panel
Collection Method:curation

PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Efficacy

clopidogrel response - Metabolism/PK Other:1
Mar 24, 2021
PharmGKB
Significance:drug response
Review Status:reviewed by expert panel
Collection Method:curation

PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Metabolism/PK

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.59
.;.;D
Eigen
Benign
0.15
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.95
D;D;D
MetaRNN
Benign
0.034
T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Pathogenic
3.2
.;M;M
PhyloP100
0.89
PrimateAI
Benign
0.40
T
PROVEAN
Pathogenic
-6.6
D;D;D
REVEL
Benign
0.24
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.29
MPC
0.23
ClinPred
0.059
T
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.94
gMVP
0.73
Mutation Taster
=66/34
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71647871; hg19: chr16-55857570; COSMIC: COSV107467882; API